Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
First Solar FSLR Stock Buyback Authorization Smart Money Outflows 20260415 MMA Mixed Martial Arts Group Limited Ordinary Shares Q3 2024 revenue falls 634 percent shares rise 448 percent in todays trade Frontdoor FTDR Stock Breakout Level Buying Pressure 20260415 Is Covista CVSA stock respecting technical levels At Highs 20260420 Market Wrap SP 500 edges lower as tech lags volatility stays elevated Nuveen NVG Stock Month Review Flirts with Support 20260422 Lincoln LNCD Stock Review Buy Sell or Hold Decision Earnings Report Is Quest Diag DGX Undervalued at 18724 20260515 Beyond Oil and Iran Inflation Pressures Reaccelerating in Services Rent and Other Sectors US Housing Market Eyes Spring Rebound as Seasonal Trends Shift Netflix Sentiment Improves After Video Streamers Upfront Presentation Fed Chair Powell at Crossroads Criminal Probe Concluded Decision on Future Looms What Oncolytics ONCYs 553 Decline Means for Investors 20260518 NYT Expands Puzzle Offerings with Pips Game Potentially Boosting Digital Engagement Bata India Targets 3000 Stores Doubles Down on Digital and Premium Growth Parliamentary Panel to Examine West Asia Crisis Impact on Indias Maritime Trade and Seafarer Safety Plus500 Reports 11 Quarterly Revenue Growth Reaffirms FullYear Guidance US and Iran Signal Progress in Talks but Key Disagreements Over Uranium and Strait of Hormuz Remain UK Brewery Contraction Signals End of Beer Boom Era Verrica Pharmaceuticals VRCA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Stage Continues OneSpan Q1 2026 Earnings EPS Beat Drives 234 Stock Gain Amid Solid Execution Imperial Oil Q1 2026 Earnings EPS Misses Estimates by 1955 Stock Edges Lower ACIU Q1 2026 Earnings NarrowerthanExpected Loss as Pipeline Progress Continues SPMC Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Environment Jade Biosciences Inc JBIO Q1 2026 Earnings Clinicalstage Biotech Misses Consensus as Cash Burn Accelerates Gamehaus Holdings GMHS Slips 5 as Stock Approaches Key Support at 092 Compass Therapeutics CMPX Breaks Out Biotech Stock Rallies 6 Toward Resistance Edgewise Therapeutics EWTX Holds Steady Near Support Amid Biotech Trading Lull C1 Fund Inc CFND Edges Lower Amid Modest Declines Support and Resistance Levels in Focus Rithm Property Trust RPT Slides 145 Approaches Critical Support Zone